Letter to the Editor: Emergency Research Consent Waiver—A Proper Way

Click to increase image sizeClick to decrease image size

Since 2003, Adil E. Shamoo has served as a paid ethics consultant to the Restore Effective Survival in Shock (RESUS) trial, the Naval Medical Research Center's (NMRC) proposed clinical trial of Hemopure®, a prehospital resuscitative fluid in trauma subjects with hemorrhagic shock. Dr. Shamoo also is a member of the RESUS trial Advisory Board. Dr. Shamoo has never had any financial relationship with the Biopure Corportation, the manufacturer of Hemopure®. Dr. Shamoo wrote this article on his own time and on his own volition.